Media Contact
Have media inquiries? Contact us between 9 a.m. and 5 p.m. ET, Monday through Friday:
- Andrea Greif
Vice President, Communications
(914) 821-8958
andrea.greif@lls.org
The Leukemia & Lymphoma Society Announces Board of Directors Officer Appointments and Welcomes Four New Members
RYE BROOK, NY, July 20, 2020 - The Leukemia & Lymphoma Society (LLS) announced today National Board Officer appointments and four new members to its National Board of Directors, who will work alongside LLS leadership to ensure that the organization continues to deliver its cancer curing mission and impact for patients, despite the challenges caused by the COVID-19 pandemic. Effective J...
A Message From Dr. Louis J. DeGennaro, President and CEO of The Leukemia & Lymphoma Society
One of the things that I value most about leading The Leukemia & Lymphoma Society (LLS) is seeing our talented, dedicated and relentless staff and volunteers in action. During these trying times, they have adapted and rallied behind our mission like never before. The past few months have been extremely difficult for all of us at LLS. The COVID-19 pandemic and its impact on the economy has dealt a major setback...
LLS, The Mark Foundation for Cancer Research and The Paul G. Allen Frontiers Group Partner to Award $6.75M in New Grants to Drive the Next Wave of Novel Cancer Therapies
(Rye Brook, NY, July 1, 2020) - Seeking to ignite the next major breakthroughs to treat blood cancers, The Leukemia & Lymphoma Society (LLS), The Mark Foundation, and The Paul G. Allen Frontiers Group today announced more than $6.75 million awarded to nine of the most exceptional scientists in the field. The innovative Blood Cancer Discoveries Grant Program is designed to encourage researchers with deep experi...
LLS Announces Collaboration with the National Cancer Institute and Children’s Oncology Group on a Global Master Clinical Trial for Children with Acute Leukemia
June 17, 2020 (Rye Brook, NY) - The Leukemia & Lymphoma Society (LLS) announced today a collaboration with the National Cancer Institute (NCI) and the Children’s Oncology Group (COG) to launch a global precision medicine clinical trial for children with acute leukemia. The three organizations share a commitment to address the urgent need for new, more precise and more effective treatments for children with canc...
Patient Groups Warn: Administration Policy Encourages Discrimination in health care
June 15, 2020 – Today 29 patient and consumer groups representing millions of people nationwide with pre-existing health conditions issued the following statement in response to administration’s final rule. The rule, finalized Friday, attempts to undermine Section 1557 of the Affordable Care Act by removing explicit protections against discrimination of patients by providers and institutions: “By finalizing ...
Engine Shop Announces New Fundraising Program Connecting Gaming Community with LLS
NEW YORK, June 16, 2020 – Individuals and communities nationwide are tapping into their inner creativity and survival skills to pivot to a virtual way of living. A campaign developed by Engine Shop, a leading engagement marketing agency, will connect a community of generous gamers with the lifesaving work of The Leukemia & Lymphoma Society (LLS), a global leader in the fight against cancer. The campaign ...
THOUSANDS ACROSS THE NATION TO STEP UP TO TAKE CANCER DOWN
See full multimedia release here Rye Brook, NY (May 14, 2020) – In a world of uncertainty, one thing is for sure — cancer doesn’t stop during a global crisis. On Saturday, June 13, The Leukemia & Lymphoma Society (LLS) will host a trailblazing event, Big Virtual Climb - 61 stories and 1,762 steps up San Francisco’s iconic Salesforce Tower, to support LLS’s investment in groundbreaking research t...
LLS and Partners Commit $4.5 Million For Blood Cancer Patients Impacted By COVID-19
Rye Brook, NY – April 1, 2020 – In the wake of the COVID-19 pandemic, The Leukemia & Lymphoma Society (LLS), a global leader in the fight against cancer, along with valued partners, announced their commitment to help as many blood cancer patients as possible during this unprecedented crisis. The LLS COVID-19 Patient Financial Aid Program will begin immediately to provide $250 to eligible patients struggl...